Evidence builds for mesenchymal stem cell therapy in MS

NEW ORLEANS – Repeated intrathecal administration of autologous mesenchymal bone marrow-derived stromal stem cells for the treatment of multiple sclerosis was safe and induced accelerated beneficial...
Source: Clinical Neurology News - Category: Neurology Source Type: news